Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

QURE:US

26.0900 USD 0.2800 1.06%

As of 20:10:00 ET on 04/24/2015.

Snapshot for uniQure B.V. (QURE)

Open: 26.8000 Day's Range: 26.0100 - 26.8999 Volume: 225,740
Previous Close: 26.3700 52wk Range: 8.2900 - 35.5000 1-Yr Rtn: +137.18%

Stock Chart for QURE

No chart data available.
  • QURE:US 26.0900
  • 1D
  • 1M
  • 1Y
26.3700
Interactive QURE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for QURE

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -2.0622
Est. EPS (EUR) (12/2015) -1.1630
Est. PEG Ratio -
Market Cap (M USD) 559.11
Shares Outstanding (M) 21.43
30 Day Average Volume 451,316
Price/Book (mrq) 7.6329
Price/Sale (ttm) 91.8912
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 06/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for QURE

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for QURE

UNIQURE B.V. develops gene therapy products that offer the prospect of long-term and potentially curative benefit to patients with genetic or acquired diseases by directing the expression of a therapeutic protein or restoring the expression of a missing protein through a single administration.

Jorn AldagCEO/Member-Mgmt BoardMatthew C KapustaChief Financial Officer
Eric GoossensChief Operating OfficerHans PreustingChief Business Officer
More Company Profile & Key Executives for QURE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil